Metsa Board Corp. Series B
Metsä Board Oyj engages in the folding boxboard, fresh fibre linerboard, and market pulp businesses in Finland and internationally. It also provides white kraft liners and lightweight fresh fibre paperboards. It offers its products to brand owners, packaging converters, manufacturers of corrugated products and merchants, and consumer and retail packaging industries. The company was formerly known… Read more
Metsa Board Corp. Series B (0O7A) - Net Assets
Latest net assets as of September 2021: €1.65 Billion EUR
Based on the latest financial reports, Metsa Board Corp. Series B (0O7A) has net assets worth €1.65 Billion EUR as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.77 Billion) and total liabilities (€1.12 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.65 Billion |
| % of Total Assets | 59.39% |
| Annual Growth Rate | 5.83% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.29 |
Metsa Board Corp. Series B - Net Assets Trend (2017–2020)
This chart illustrates how Metsa Board Corp. Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Metsa Board Corp. Series B (2017–2020)
The table below shows the annual net assets of Metsa Board Corp. Series B from 2017 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | €1.38 Billion | +3.42% |
| 2019-12-31 | €1.34 Billion | +1.14% |
| 2018-12-31 | €1.32 Billion | +13.33% |
| 2017-12-31 | €1.17 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Metsa Board Corp. Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 463.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €450.10 Million | 32.53% |
| Common Stock | €557.90 Million | 40.32% |
| Other Components | €375.80 Million | 27.16% |
| Total Equity | €1.38 Billion | 100.00% |
Metsa Board Corp. Series B Competitors by Market Cap
The table below lists competitors of Metsa Board Corp. Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chung Hung Steel Corp
TW:2014
|
$465.24 Million |
|
Meitec Corporation
MU:MJ1
|
$465.27 Million |
|
Tatwah Smartech Co Ltd
SHE:002512
|
$465.34 Million |
|
Armada Hflr Pr
NYSE:AHH
|
$465.35 Million |
|
BOKU INC. REG S DL-0001
F:B04
|
$465.05 Million |
|
MiMedx Group Inc
NASDAQ:MDXG
|
$464.97 Million |
|
Jiayuan Science and Technology Co.Ltd.
SHE:301117
|
$464.79 Million |
|
HERTZ GL. HOLD. INC. NEW
F:AZK0
|
$464.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Metsa Board Corp. Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 1,338,000,000 to 1,383,800,000, a change of 45,800,000 (3.4%).
- Net income of 170,100,000 contributed positively to equity growth.
- Dividend payments of 85,300,000 reduced retained earnings.
- Other factors decreased equity by 39,000,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €170.10 Million | +12.29% |
| Dividends Paid | €85.30 Million | -6.16% |
| Other Changes | €-39.00 Million | -2.82% |
| Total Change | €- | 3.42% |
Book Value vs Market Value Analysis
This analysis compares Metsa Board Corp. Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Metsa Board Corp. Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.29%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.00%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 1.66x
- Recent ROE (12.29%) is below the historical average (12.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 12.89% | 8.14% | 0.83x | 1.91x | €33.77 Million |
| 2018 | 15.38% | 10.46% | 0.85x | 1.73x | €71.11 Million |
| 2019 | 10.81% | 7.49% | 0.85x | 1.70x | €10.80 Million |
| 2020 | 12.29% | 9.00% | 0.82x | 1.66x | €31.72 Million |
Industry Comparison
This section compares Metsa Board Corp. Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Metsa Board Corp. Series B (0O7A) | €1.65 Billion | 12.89% | 0.68x | $465.19 Million |
| Nyfosa AB (0A0K) | $13.33 Billion | 16.69% | 1.39x | $961.70 Million |
| Tethys Oil AB (0A1V) | $256.60 Million | 6.51% | 0.11x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $12.04 Billion | -3.01% | 0.06x | $258.24 Million |
| Strategy Inc (0A7O) | $605.73 Million | 3.00% | 0.54x | $37.86 Billion |
| NACON SASU (0A9N) | $40.77 Million | 2.41% | 0.74x | $7.35 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $579.46 Million |
| Truecaller AB Series B (0AA7) | $145.93 Million | -10.64% | 1.99x | $271.46 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $75.78 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $39.07 Million | -39.37% | 0.22x | $71.96 Million |
| Kalray S.A. (0ABT) | $54.02 Million | -28.78% | 0.63x | $33.84 Million |